Holen Sie sich die Stockscreener-App
7.8896
0.19%
-0.0104
Schlusskurs vom Vortag:
$7.90
Offen:
$7.78
24-Stunden-Volumen:
2.38M
Relative Volume:
0.21
Marktkapitalisierung:
$5.34B
Einnahmen:
$6.55B
Nettoeinkommen (Verlust:
$-530.20M
KGV:
-10.14
EPS:
-0.7777
Netto-Cashflow:
$495.00M
1W Leistung:
+3.89%
1M Leistung:
-3.49%
6M Leistung:
-44.04%
1J Leistung:
-47.88%
1-Tages-Spanne:
$7.73
$7.935
1-Wochen-Bereich:
$7.55
$8.065
52-Wochen-Spanne:
$7.265
$16.17
Avantor Inc Stock (AVTR) Company Profile
Firmenname
Avantor Inc
Sektor
Telefon
(610) 386-1700
Adresse
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
7.895 | 5.34B | 6.55B | -530.20M | 495.00M | -0.7777 |
ISRG
Intuitive Surgical Inc
|
451.38 | 160.56B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.07 | 43.95B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.40 | 36.34B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
43.65 | 35.94B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
224.11 | 32.65B | 5.40B | 1.49B | 1.78B | 10.12 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2026-01-05 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-12-17 | Herabstufung | Jefferies | Hold → Underperform |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-11-04 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-29 | Herabstufung | Goldman | Buy → Neutral |
| 2025-04-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-04-28 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-17 | Herabstufung | UBS | Buy → Neutral |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-10-05 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-09-14 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-09-09 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-30 | Fortgesetzt | Raymond James | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Eingeleitet | Goldman | Buy |
| 2021-04-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-08-02 | Eingeleitet | Cleveland Research | Neutral |
| 2019-06-14 | Eingeleitet | Janney | Buy |
| 2019-06-12 | Eingeleitet | Raymond James | Outperform |
| 2019-06-11 | Eingeleitet | Goldman | Buy |
| 2019-06-11 | Eingeleitet | Guggenheim | Buy |
| 2019-06-11 | Eingeleitet | JP Morgan | Overweight |
| 2019-06-11 | Eingeleitet | Jefferies | Buy |
| 2019-06-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-06-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-11 | Eingeleitet | SunTrust | Buy |
| 2019-06-11 | Eingeleitet | UBS | Buy |
| 2019-06-11 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Avantor Inc Aktie (AVTR) Neueste Nachrichten
Sectors Review: Is Avantor Inc still a buy after recent gains2026 Growth vs Value & Accurate Buy Signal Notifications - baoquankhu1.vn
Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026 - Sahm
Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates - msn.com
Why The Narrative Around Avantor (AVTR) Is Shifting After Target Cuts And Leadership Changes - Yahoo Finance
Avantor to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026 - bitget.com
Avantor, Inc. (AVTR) stock price, news, quote and history - Yahoo Finance Singapore
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Avantor (AVTR) and Veeva Systems (VEEV) - The Globe and Mail
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation | NYSE:AVTR | Press Release - Stockhouse
SG Americas Securities LLC Acquires 272,093 Shares of Avantor, Inc. $AVTR - MarketBeat
AVTR Stock Price, Quote & Chart | AVANTOR INC (NYSE:AVTR) - ChartMill
Avantor, Inc. (AVTR) Stock forecasts - Yahoo Finance UK
Avantor CFO R. Brent Jones to depart by late June - Investing.com Australia
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
Avantor stock holds at Market Perform as CFO departs, guidance intact - Investing.com India
How Investors Are Reacting To Avantor (AVTR) CFO Succession and Interim Finance Leadership Shift - simplywall.st
Avantor, Inc. Announces CFO Transition in April 2026 Press Release - Minichart
R. Brent Jones to Leave as Executive Vice President of Avantor, Inc., Effective on or Before June 24, 2026 - marketscreener.com
Avantor Announces CFO Resignation and Interim Finance Leadership - TipRanks
Avantor (AVTR) plans CFO change, names interim finance chief and reaffirms 2026 guidance - Stock Titan
AVANTOR INCREAFFIRMS FISCAL 2026 FINANCIAL GUIDANCE - Moomoo
Avantor finance chief exits; Steve Eck to step in as interim CFO - Stock Titan
Avantor’s Stubblefield Talks Innovation, Sustainability With Axios - CSRwire
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Trade Recap: Does Avantor Inc align with a passive investing strategy2026 Reactions & Accurate Intraday Trade Tips - baoquankhu1.vn
Avantor, Inc. Hits New 52-Week Low at $7.27 Amidst Declining Performance - Markets Mojo
Why a $3.5 Million Bet Targets Avantor Amid a 54% Stock Drop - AOL.com
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
[ARS] Avantor, Inc. SEC Filing - Stock Titan
Form DEFA14A Avantor, Inc. - StreetInsider
Avantor (AVTR) 2026 proxy: new CEO, Revival plan and 2025 results - Stock Titan
Avantor taps veteran dealmaker as board eyes a high-stakes turnaround - MSN
Vanguard realigns holdings; reports 0 Avantor shares (AVTR) - Stock Titan
A Look At Avantor (AVTR) Valuation After Prolonged Share Price Weakness - Yahoo Finance
Assenagon Asset Management S.A. Takes Position in Avantor, Inc. $AVTR - marketbeat.com
EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks - Benzinga
EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks - Benzinga
Avantor stock hits 52-week low at $7.38 amid market challenges - Investing.com Australia
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Investors to Connect - ACCESS Newswire
Avantor (NYSE:AVTR) Reaches New 12-Month LowTime to Sell? - MarketBeat
EDGAR Filing Documents for 0001628280-25-046936 - SEC.gov
Avantor, Inc. Hits New 52-Week Low at $7.39 Amidst Major Decline - Markets Mojo
Research Alert: CFRA Maintains Hold Rating On Shares Of Avantor - Moomoo
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Why a $3.5 Million Wager Focuses on Avantor After a 54% Share Price Decline - Bitget
Circumference Group's New Avantor Investment: A 3.5M Dollar PositionNews and Statistics - IndexBox
Avantor Inc stock faces pressure amid weak FY2026 guidance and market selloff - AD HOC NEWS
Avantor, Inc. $AVTR Shares Acquired by Greenhaven Associates Inc. - marketbeat.com
Finanzdaten der Avantor Inc-Aktie (AVTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):